HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lauder Raises FY 2022 Outlook As Sales Exceed Pre-Pandemic Levels

Executive Summary

The Estee Lauder Companies’ net sales in the fiscal 2022 second quarter climbed 14% to $5.54bn, surpassing pre-pandemic results. The New York-based beauty giant raised its full-year sales and earnings guidance, with plans for impactful innovations in addition to strategic near-term pricing.

You may also be interested in...



L’Oréal Strongest In Beauty ‘Brand Impact,’ While Lauder Gaining Value Fastest

L’Oréal is the most valuable beauty brand globally, according to consultancy Brand Finance’s annual report from its methodology ranking 50 most valuable brands in cosmetics, skin care, hair care and personal care. Estee Lauder ranked second.

Lauder Slashes FY 2022 Outlook On China Woes Despite ‘Makeup Renaissance’ In Other Regions

Estee Lauder says a strict COVID-related lockdown in China prompted an adjustment in full-year sales projections to 7%-9% growth, about half of its was earlier estimate. Global fragrance sales jumped reported 28% in latest quarter to $579m and makeup sales increased 9% to $1.11bn.

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152183

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel